CLINICAL TRIALS PROFILE FOR PAFOLACIANINE SODIUM
✉ Email this page to a colleague
All Clinical Trials for PAFOLACIANINE SODIUM
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT06915727 ↗ | An Imaging Agent (Pafolacianine) for Identifying Lesions in Pediatric Patients With Primary or Metastatic Solid Tumors | RECRUITING | Mayo Clinic | PHASE3 | 2025-04-15 | This phase III trial studies how well pafolacianine works for identifying cancerous lesions in children and adolescent patients with primary solid tumors or solid tumors that have spread from where they first started (primary site) to other places in the body (metastatic). Pafolacianine is a fluorescent imaging agent that targets folate receptors which are overexpressed in many cancers and is used with near infrared (NIR) imaging during surgery to identify tumor cells. NIR uses a special camera that uses wavelengths in the infrared range to visualize and locate the tumor cells that are lit up by the pafolacianine. Giving pafolacianine for NIR imaging may work better than other imaging agents in identifying cancerous lesions in pediatric patients with solid tumors. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for PAFOLACIANINE SODIUM
Condition Name
| Condition Name for PAFOLACIANINE SODIUM | |
| Intervention | Trials |
| Malignant Neck Neoplasm | 1 |
| Malignant Pelvic Neoplasm | 1 |
| Metastatic Childhood Malignant Solid Neoplasm | 1 |
| Childhood Malignant Solid Neoplasm | 1 |
| [disabled in preview] | 1 |
| This preview shows a limited data set Subscribe for full access, or try a Trial | |
Clinical Trial Locations for PAFOLACIANINE SODIUM
Trials by Country
Clinical Trial Progress for PAFOLACIANINE SODIUM
Clinical Trial Phase
Clinical Trial Sponsors for PAFOLACIANINE SODIUM
Sponsor Name
